2022
Longitudinal serum proteomics analyses identify unique and overlapping host response pathways in Lyme disease and West Nile virus infection
Boada P, Fatou B, Belperron A, Sigdel T, Smolen K, Wurie Z, Levy O, Ronca S, Murray K, Liberto J, Rashmi P, Kerwin M, Montgomery R, Bockenstedt L, Steen H, Sarwal M. Longitudinal serum proteomics analyses identify unique and overlapping host response pathways in Lyme disease and West Nile virus infection. Frontiers In Immunology 2022, 13: 1012824. PMID: 36569838, PMCID: PMC9784464, DOI: 10.3389/fimmu.2022.1012824.Peer-Reviewed Original ResearchConceptsWest Nile virus infectionLyme diseaseVirus infectionWNV infectionSerum proteomeSymptomatic WNV infectionTime of diagnosisHealthy control seraDisseminated Lyme diseaseHost response pathwaysExtracellular bacterial infectionsSerum proteomic analysisIntracellular viral infectionsViral infectionHost responseBacterial infectionsControl seraStudy participantsInfectionDiseaseDisease biomarkersEarly diagnosticsLC/MSMolecular mechanismsRecovery phase
2009
Serum Nogo-A levels are not elevated in amyotrophic lateral sclerosis patients
Harel NY, Cudkowicz ME, Brown RH, Strittmatter SM. Serum Nogo-A levels are not elevated in amyotrophic lateral sclerosis patients. Biomarkers 2009, 14: 414-417. PMID: 19548774, PMCID: PMC2842187, DOI: 10.1080/13547500903056051.Peer-Reviewed Original ResearchConceptsAmyotrophic lateral sclerosisALS patientsHealthy controlsAmyotrophic lateral sclerosis patientsHealthy control seraInvasive diagnostic methodsSclerosis patientsLateral sclerosisPatientsControl seraMuscle contentSerum samplesElevated levelsAdditional studiesSerumDiagnostic methodsLarge percentageSclerosisLevelsDiagnosisControlBiomarkersNogoNM
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply